Literature DB >> 6459760

Mezlocillin disposition in chronic hemodialysis patients.

D M Janicke, A Mangione, R W Schultz, W J Jusko.   

Abstract

The pharmacokinetics of a single 1-g intravenous dose of mezlocillin were examined in six functionally anephric patients undergoing hemodialysis. Hemodialysis clearance calculated by plasma extraction ratios across the dialyzer membrane and by dialysis fluid agree well, averaging 26 and 32 ml/min. Dialyzer extraction ratios averaged 0.16 +/- 0.07, and 23.3 +/- 9.6% of the dose was measured in the dialysate. Plasma clearances (104 +/- 45 ml/min) and steady-state volumes of distribution (0.22 +/- 0.07 liter/kg) of mezlocillin showed good agreement with literature values. The nonrenal clearance (4.25 +/- 2.30 liters/h per 1.73 m2) of mezlocillin was appreciable. Drug loss by hemodialysis is small and should have little effect on therapeutic dosage needs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6459760      PMCID: PMC181757          DOI: 10.1128/AAC.20.5.590

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Kinetics of intravenous mezlocillin in chronic hemodialysis patients.

Authors:  E Francke; S Mehta; H C Neu; G B Appel
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

3.  Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects.

Authors:  W J Jusko; G P Lewis; G W Schmitt
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Azlocillin and mezlocillin, two new alpha-amino-substituted penicillins. A comparison of the in vitro activity with other penicillins.

Authors:  R Wise
Journal:  Arzneimittelforschung       Date:  1979

6.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

7.  Pharmacokinetics of mezlocillin in healthy volunteers.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

8.  Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.

Authors:  J Kosmidis; P Doundoulaki; C Stathakis; N Zerefos; A Bounia; G K Daikos
Journal:  Arzneimittelforschung       Date:  1979

9.  Artificial kidneys and clearance calculations.

Authors:  T P Gibson; E Matusik; L D Nelson; W A Briggs
Journal:  Clin Pharmacol Ther       Date:  1976-12       Impact factor: 6.875

10.  Mezlocillin in the therapy of serious infections.

Authors:  S J Pancoast; J A Jahre; H C Neu
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

View more
  2 in total

Review 1.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 2.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.